Target intelligence / Profile preview

Nervous system tissue

Molecular classification
Other
01

Overview

Nervous system tissue is a specialized biological structure composed of neurons, which transmit electrical impulses, and glial cells, which provide support and protection (StatPearls, 2023). It is divided into the central nervous system (CNS) and the peripheral nervous system (PNS), serving as the primary site for sensory integration and motor output (NIH, 2022). While many drugs are designed to act within this tissue, "Nervous system tissue" itself is a physiological system rather than a discrete molecular therapeutic target like a specific receptor or enzyme (UniProt, 2024). Pathological changes in this tissue are central to conditions such as Alzheimer's disease, multiple sclerosis, and chronic pain (PubMed, 2023). Pharmacological challenges include ensuring drug delivery across the blood-brain barrier and minimizing systemic neurotoxicity (Nature Reviews Drug Discovery, 2022). Therapeutic interventions often focus on modulating specific neurotransmitter systems or protecting neuronal integrity within the tissue environment. The complexity of the tissue's architecture makes it difficult to achieve localized effects without affecting broader neural circuits. Consequently, drug development for nervous system disorders requires high specificity for molecular targets to avoid adverse psychiatric or motor side effects.

Other names
Neural tissueNerve tissueNervous system
02

Mechanism of action

Not applicable for tissue-level entries; drugs acting within this tissue target specific molecular components such as receptors, ion channels, or enzymes.

03

Biological functions

Signal transductionSensory perceptionMotor controlHomeostasisCognition
04

Disease associations

Neurodegenerative diseaseNeuropathic painEpilepsyMultiple sclerosisPsychiatric disorders
05

Safety considerations

NeurotoxicityBlood-brain barrier penetrationOff-target central nervous system effects
06

Biomarkers

Neurofilament light chain (NfL)Glial fibrillary acidic protein (GFAP)Amyloid-betaTau protein

Beyond the preview

Go deeper on Nervous system tissue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nervous system tissue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call